Login
$EMBC
$6.80 +$0.09 (1.34%) Close

Company Executives

$EMBC Management Team

Mr. Devdatt Kurdikar

Chairman of the Board

President

Chief Executive Officer

Age 57
Compensation $9.400M USD
Sex Male

Mr. Jacob Elguicze

Chief Financial Officer

Senior Vice President

Age 52
Compensation $3.459M USD
Sex Male

Ms. Jean Casner

Chief Human Resources Officer

Senior Vice President

Age 67
Compensation $1.730M USD
Sex Female

Mr. Jeffrey Mann

Senior Vice President

General Counsel

Product Development

Age 53
Compensation $3.005M USD
Sex Male

Mr. Tom Blount

Senior Vice President and President

North America

Age 52
Compensation -
Sex Male

Mr. Shaun Curtis

Senior Vice President - Global Manufacturing

Supply Chain and Quality

Age 56
Compensation $2.065M USD
Sex Male

Mr. Slobodan Radumilo

Senior Vice President and President - International

Age 55
Compensation -
Sex Male

Mr. Pravesh Khandelwal

Investor Relations

Age -
Compensation -
Sex Male

Mr. Anthony Roth

Vice President

Chief Accounting Officer

Corporate Controller

Age 52
Compensation -
Sex Male

Ms. Ginny Blocki

Senior Vice President - Strategy

Age -
Compensation -
Sex Female
Directors
7
serving now
Independent
6 of 7
stated in the proxy
Average tenure
3.0 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2025 pay Source
Carrie L. Anderson
57 2022
3 years
Independent
Audit Corporate Governance and Nominating
None stated $317,004
Robert (Bob) J. Hombach
59 2022
3 years
Independent
Audit · Chair Compensation and Management Development Committee
BioMarin Pharmaceutical Inc., Henry Schein, Inc. $332,004
Devdatt (Dev) Kurdikar
57 2022
3 years
Not independent None stated Zimmer Biomet Holdings, Inc. Paid as CEO
Milton M. Morris
55 2022
3 years
Independent
Compensation and Management Development Technology, Quality and Regulatory
Myomo, Inc. $317,004
Claire Pomeroy
70 2022
3 years
Independent
Corporate Governance and Nominating · Chair
Haemonetics Corporation $333,004
Karen N. Prange
61 2022
3 years
Independent
Corporate Governance and Nominating
AtriCure, Inc. $328,004
Christopher R. Reidy
69 2022
3 years
Independent
Technology, Quality and Regulatory · Chair Audit
None stated $331,754

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Dec 18, 2025 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support